SUSAN MIEDECKE: Open Payments
NPI 1821103870 · SCOTT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,747 in 119 payments from 14 companies in 2025. Trend: 2023 $1,184 · 2024 $1,262 · 2025 $1,747
Food & beverage: $1,663Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $591 |
| Janssen Biotech, Inc. | 9 | $234 |
| Ardelyx, Inc. | 16 | $224 |
| Gilead Sciences, Inc. | 13 | $156 |
| Ipsen Biopharmaceuticals, Inc | 6 | $131 |
| Phathom Pharmaceuticals, Inc. | 11 | $83 |
| PFIZER INC. | 4 | $64 |
| Madrigal Pharmaceuticals | 4 | $63 |
| Lilly USA, LLC | 3 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $50 |
Products named: TREMFYA, IBSRELA, RINVOQ, CREON, SKYRIZI, IQIRVO, VOQUEZNA, XELJANZ.
Industry payments across LA — which companies pay providers there.
